3rd European Conference on Oncology Cancer Therapy is an award-winning international conference that encourages effective knowledge transfer and best practices exchange amongst over 250 cancer control and public health experts from 50 countries. It aims to strengthen the participant’s action and impact on national, regional, and international scales through a multidisciplinary program that features the latest successful interventions in cancer prevention, diagnosis, treatment, and care.

Cancer and Radiotherapy Conference

We invite scientists, researchers, educators and students, industry, investors, and people from all walks of life who are interested in Cancer Science Research to attend the conference and share their experiences and innovations with others, as well as explore opportunities for collaboration.

ABOUT ONCOLOGY CANCER 

The 3rd European Conference on Oncology Cancer Therapy is scheduled on July 17-18, 2023 in Rome, Itlay. Cancer Conference 2023 runs with the theme “The Future of Oncology: Emerging Technologies and Treatment Strategies”. We are beaming to welcome all the leading researchers, delegates, scientists, scholars, and professors to take part in this approaching conference to witness precious scientific discussions and bestow future innovations in the treatment in the field of Cancer, Oncology. This Conference will emphasize the informative research on its impact on clinical outcomes, through poster and oral demonstrations, educational workshop sessions, and noteworthy plenary presentations. Cancer Conference is a perfect podium to find out how cancer research advances obliging the Medical, Health, and human society. Cancer Conference will principally highlight the recent matters during the event, which reflect present education, developments, research, and innovations globally in the field of cancer, oncology, and medical sectors.

WHY SHOULD YOU ATTEND?

• Participate in one of the most powerful connecting platforms in cancer conferencel.
• Raise your voice on a global stage and contribute to accelerating progress in the fight against cancer - here
• Engage in person with the most influential experts and leaders in global cancer and radiotherapy conference
• Make valuable and inspirational connections through facilitated networking 
• Join one of the education and training opportunities offered as part of the program

Registration is now open for Cancer Conference 2023. The Scientific Program Committee is formalizing the program schedule, which will provide ample opportunities for networking with colleagues and old friends in the Cancer Research World.

EARLY BIRD REGISTRATION END: MAY 01, 2023 (ON OR BEFORE)

ADVANCE BOOKING : JULY 22, 2023 ( ON OR BEFORE)

ON-SITE BOOKING: SEPTEMBER 01, 2022 (ON OR BEFORE)

We have special collobration with Onkologia I Radioterapia is an international peer reviewed journal which publishes on both clinical and pre-clinical research related to cancer. You can publish your full article at Onkologia i Radioterapia (ISSN 1896-8961) at Low article publishing charge.

Indexed and Abstracted with: 
 SCOPUS | SCImago | MIAR | Cancer Index | Medical Project Poland |  Russian Science Citation Index (RSCI) Powered by Clarivate Analytics

PARTICIPATION OPTIONS

Cancer Conference 2022 provides the participants with different modes or ways to participate such as Delegate or Speaker under ACADEMIC / STUDENT / BUSINESS Category. 

1.    Keynote speaker: 45-50 minutes

2.    Speaker (oral presentation): 25-30 minutes (only one person can present)

3.    Speaker (workshop): 45-50 minutes (more than 1 can present)

4.    Speaker (special session): 45-50 minutes (more than 1 can present)

5.    Speaker (symposium): more than 45 minutes (more than 1 can present)

6.    Delegate (only registration): will have access to all the sessions with all the benefits of registration

7.    Poster presenter:  can present a poster and enjoy the benefits of delegate

8.    Remote attendance:  can participate via video presentation or e-poster presentation

9.    Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes

10.  Media partner

11.  Sponsor

12.  Collaborator

Market Analysis

Cancer is a global health problem that affects people of all ages, genders, and ethnicities. According to the World Health Organization (WHO), cancer is the second leading cause of death worldwide, accounting for an estimated 14.6 million deaths in 2023. The incidence of cancer is also increasing globally, with an estimated 18.1 million new cases and 14.6 million deaths from cancer in 2023.

The global cancer market is expected to grow at a significant rate due to several factors such as the increasing aging population, changing lifestyles, growing awareness about cancer, and technological advancements in cancer treatment. In 2023, the global oncology market was valued at USD 150.0 billion and is expected to reach USD 297.3 billion by 2026, at a CAGR of 8.7% during the forecast period.

The market analysis of cancer patients in different regions shows that the burden of cancer is highest in low- and middle-income countries. According to WHO, more than 70% of cancer deaths occur in these countries, despite having lower cancer incidence rates compared to high-income countries. The most common cancers in low- and middle-income countries are breast, cervical, and lung cancer, while prostate, colorectal, and lung cancer are the most common in high-income countries.

In terms of cancer treatments, chemotherapy, and radiation therapy are the most commonly used methods of cancer treatment worldwide. However, targeted therapy and immunotherapy are gaining popularity due to their ability to target cancer cells more precisely, with fewer side effects.

Overall, the global cancer market is expected to continue to grow due to the increasing prevalence of cancer, the aging population, and technological advancements in cancer treatment. However, the burden of cancer remains highest in low- and middle-income countries, highlighting the need for increased access to cancer prevention, screening, and treatment in these regions.

The Asia-Pacific cancer therapy market is expected to observe good growth owing to the rising prevalence of cancer, growing government initiatives for cancer awareness, and increasing patient assistance programs (PAPs). Lung, stomach, colorectum, liver, and esophagus are the most common types of cancer in China. The increasing prevalence of cancer burden and thus, cancer therapies is due to a number of factors, including population growth, aging, environmental pollution, and unhealthy dietary habits. In addition, cigarette smoking, in particular, has also continued to be prevalent in the Asia-Pacific region. The rising prevalence of cancer, thus helps the market to grow over the forecast period. The target therapy segment is expected to show a good CAGR over the forecast period. The targeted therapy includes hormone therapies, gene expression modulators, apoptosis inducers, angiogenesis inhibitors, immunotherapies, signal transduction inhibitors, and toxin delivery molecules. Targeted therapy is attaining importance due to its specificity toward cancer cells while sparing the toxicity to off-target cells.

The other major factors driving the growth of the segment are an increase in R&D and the rising prevalence of various types of cancer across the globe. Targeted therapy is a treatment for cancer that is unlike the traditional chemotherapy used for cancer. The drugs for target therapy work by targeting the specific genes or proteins that are present in the cancer cells. 

The global cancer burden increased to 19.3 million cases and 10 million deaths in 2020, according to new estimates from the International Agency for Research on Cancer's Global Cancer Observatory, and is expected to rise to more than 30 million cases and over 16 million deaths by 2040, with the majority of the increases occurring in low- and middle-income countries. Cancer incidence and mortality are increasing globally due to ageing populations, limited access to preventive and oncology care services, a shortage of cancer specialists, late-stage disease presentation, medicines, and diagnostic equipment, obesity, and lifestyle choices. Cancer treatment has traditionally been regarded as one of the most important and significant clinical topics. Depending on the type and stage of cancer, a variety of approaches have been developed. It's high time for us to start providing high-quality cancer care to low-resource areas.

Our forthcoming conference will strike up conversations on the present status of cancer treatment and provide an interactive forum to hear about policies and neoteric changes that are being implemented to help reduce cancer treatment backlogs and, ultimately, improve the health of cancer patients. This two-day conference will provide a timely opportunity to hear from, learn from, and interact with some of the World's finest oncology professionals while networking with like-minded peers.

The agenda of the Cancer Congress 2022 is to promote discoveries, evaluate the system and strategic issues, and develop and maintain basic systems between analysts, experts, arrangement producers, and healthcare agents through its plenary talks, keynote sessions, oral and poster presentations. We've invited some of the world's most influential speakers including researchers, scientists, oncologists, cancer specialists, pharmacists, clinicians, academicians, young scholars, healthcare professionals, policymakers and industry representatives to provide motivational presentations and workshops.

Join us at Cancer Conference 2022 for an interactive environment aimed at improving cancer patient outcomes.